Li Shan Selected Research

Li Shan Research Topics

Disease

17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 08/2010
11	Neoplasms (Cancer) 12/2021 - 12/2007
5	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2018
3	Lymphatic Metastasis 01/2022 - 01/2015
3	Lung Neoplasms (Lung Cancer) 12/2020 - 02/2013
2	Adenocarcinoma of Lung 11/2020 - 10/2015
1	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2022
1	Retinal Perforations 05/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Sarcopenia 01/2022
1	Disease Progression 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 12/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Lymphoma (Lymphomas) 01/2019
1	Esophageal Squamous Cell Carcinoma 01/2018
1	Heart Failure 12/2017
1	Smallpox (Variola) 01/2017
1	Presbyopia 06/2016
1	Hyperthermia 01/2016
1	Leukemia 01/2016
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2015
1	Taste Disorders (Taste Disorder) 06/2015
1	Cardiotoxicity 05/2015
1	Prostatic Neoplasms (Prostate Cancer) 11/2014
1	Adenocarcinoma 01/2013
1	Glaucoma 02/2010

Drug/Important Bio-Agent (IBA)

5	ErbB Receptors (EGF Receptor)IBA 03/2019 - 01/2013
4	Pharmaceutical PreparationsIBA 11/2020 - 11/2014
4	Tyrosine Kinase InhibitorsIBA 10/2015 - 01/2013
3	CrizotinibIBA 06/2019 - 01/2019
2	MicroRNAs (MicroRNA)IBA 05/2022 - 01/2018
2	Long Noncoding RNAIBA 01/2022 - 12/2021
2	alectinibIBA 01/2022 - 01/2022
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 12/2021 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 09/2021 - 12/2020
2	Gefitinib (Iressa)FDA Link 11/2020 - 02/2013
2	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2020
1	Carcinoembryonic AntigenIBA 01/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2021
1	TOR Serine-Threonine KinasesIBA 12/2021
1	N-methyladenosineIBA 12/2021
1	Messenger RNA (mRNA)IBA 09/2021
1	osimertinibIBA 11/2020
1	HMPL-013IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 06/2019
1	Biological ProductsIBA 01/2019
1	Factor VIII (Coagulation Factor VIII)IBA 01/2019
1	GRB2 Adaptor ProteinIBA 01/2018
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2018
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2017
1	pro-brain natriuretic peptide (1-76)IBA 12/2017
1	PlatinumIBA 04/2017
1	CyclodextrinsIBA 01/2017
1	tecovirimatIBA 01/2017
1	Meglumine FDA Link 01/2017
1	Claudin-1IBA 01/2016
1	Cathepsin LIBA 01/2016
1	Therapeutic UsesIBA 10/2015
1	3- methyl- 3- azabicyclo(3,3,1)nonanyl- 9- alpha- yl- alpha- cyclopentyl- alpha- phenyl- alpha- glycolateIBA 06/2015
1	Ion Exchange ResinsIBA 06/2015
1	TabletsIBA 06/2015
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 05/2015
1	claudin 6IBA 01/2015
1	proxalutamideIBA 11/2014
1	OsteopontinIBA 01/2014
1	Bevacizumab (Avastin)FDA Link 02/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 02/2013
1	Monoclonal AntibodiesIBA 02/2013
1	ParaffinIBA 01/2013
1	Erythropoietin FDA Link 08/2012
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 08/2012
1	Coat Protein Complex I (COPI)IBA 02/2010
1	Cell Adhesion MoleculesIBA 12/2007
1	IntegrinsIBA 12/2007
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 12/2007

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 01/2022 - 08/2010
4	Therapeutics 01/2014 - 11/2010
1	Vitrectomy 05/2022
1	Adjuvant Chemotherapy 01/2022
1	Transplantation 12/2020
1	Eyeglasses (Spectacles) 06/2016
1	Brachytherapy 08/2010